O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-1.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.88B
AUM Growth
+$7.88B
(-24%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
148
New
11
Increased
16
Reduced
57
Closed
17
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Amicus Therapeutics
FOLD
|
$80.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$77.8M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$43.5M |
| 5 |
scPharmaceuticals
SCPH
|
$41.2M |
Top Sells
| 1 |
Incyte
INCY
|
$172M |
| 2 |
AET
Aetna Inc
AET
|
$171M |
| 3 |
Biogen
BIIB
|
$127M |
| 4 |
Merck
MRK
|
$105M |
| 5 |
Gilead Sciences
GILD
|
$101M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Xencor
XNCR
$580M
| $22.4M | 0.28% | 1,022,100 +274,856 | +37% | +$6.02M |
|
|
SVA
77
DELISTED
Sinovac Biotech, Ltd
SVA
| $22.4M | 0.28% | 2,839,500 +172,000 | +6% | +$1.36M |
|
78
Glaukos
GKOS
$5.5B
| $21.5M | 0.27% | 836,500 | – | – |
|
79
Medtronic
MDT
$119B
| $20.5M | 0.26% | 254,200 -624,800 | -71% | -$50.5M |
|
80
Universal Health Services
UHS
$11.6B
| $19.8M | 0.25% | 174,800 -494,200 | -74% | -$56M |
|
|
IMGN
81
DELISTED
Immunogen Inc
IMGN
| $18.2M | 0.23% | 2,834,126 -2,616,455 | -48% | -$16.8M |
|
82
Cartesian Therapeutics
RNAC
$261M
| $18.1M | 0.23% | 1,842,797 | – | – |
|
83
Novo Nordisk
NVO
$251B
| $17.7M | 0.22% | 330,000 | – | – |
|
|
STDY
84
DELISTED
SteadyMed Ltd
STDY
| $15.7M | 0.2% | 4,246,196 | – | – |
|
|
MNTA
85
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $15.7M | 0.2% | 1,125,900 -983,168 | -47% | -$13.7M |
|
|
VRNA
86
Verona Pharma
VRNA
$9.16B
| $14.8M | 0.19% | 1,250,396 +583,730 | +88% | +$6.93M |
|
87
Vanda Pharmaceuticals
VNDA
$279M
| $14.7M | 0.19% | 967,859 | – | – |
|
|
DBVT
88
DBV Technologies
DBVT
$264M
| $14.2M | 0.18% | 578,500 +65,600 | +13% | +$1.61M |
|
89
Natera
NTRA
$23.1B
| $14.2M | 0.18% | 1,576,190 | – | – |
|
90
Zai Lab
ZLAB
$3.68B
| $14M | 0.18% | 658,160 | – | – |
|
|
NVTA
91
DELISTED
Invitae Corporation
NVTA
| $13.8M | 0.17% | 1,518,197 | – | – |
|
|
CTIC
92
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $13.4M | 0.17% | 5,000,000 | – | – |
|
|
WMGIZ
93
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
| $13.2M | 0.17% | 8,746,583 +33,495 | +0.4% | +$50.6K |
|
94
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $12.9M | 0.16% | 1,471,500 +391,800 | +36% | +$3.45M |
|
|
NUVA
95
DELISTED
NuVasive, Inc.
NUVA
| $12.9M | 0.16% | 220,700 | – | – |
|
|
ADAP
96
Adaptimmune Therapeutics
ADAP
$15.6M
| $12.8M | 0.16% | 1,914,660 | – | – |
|
97
Synlogic
SYBX
$17M
| $12.8M | 0.16% | 1,314,996 | – | – |
|
|
SRRA
98
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $12M | 0.15% | 3,203,704 -500,000 | -13% | -$1.87M |
|
99
Heron Therapeutics
HRTX
$207M
| $11.8M | 0.15% | 650,000 | – | – |
|
|
AMED
100
DELISTED
Amedisys
AMED
| $10.9M | 0.14% | +207,500 | New | +$10.9M |
|